Nexlizet

Esperion's new Nexletol analyses build its case with doctors

Esperion's Nexletol cut cholesterol levels over placebo in patients who couldn't tolerate statin therapy and benefitted some women more than men.

Kyle Blankenship Nov 13, 2020 11:50am

Esperion launches DTC campaign for Nexletol with all-stock video

Oct 1, 2020 10:40am

Esperion ditches drug launch playbook during pandemic

Sep 21, 2020 11:30am